Company intelligence
MoonLake Immunotherapeutics (NASDAQ: MLTX)
Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science
Biotechnology Research
Zug, CH
140 employees
Founded 2021
2 public signals
About MoonLake Immunotherapeutics (NASDAQ: MLTX)
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
Verified activity
Signals from MoonLake Immunotherapeutics (NASDAQ: MLTX)
2 published signals
Presence & Recognition
MoonLake Immunotherapeutics (NASDAQ: MLTX) is attending the Cantor Global Healthcare Conference in New York on September 10 for investor engagement and healthcare-sector dialogue.
Reported by MoonLake Immunotherapeutics (NASDAQ: MLTX)
Presence & Recognition
MoonLake Immunotherapeutics (NASDAQ: MLTX) will be attending the Citi 2026 Biopharma Back to School Conference in New York on September 9.
Reported by MoonLake Immunotherapeutics (NASDAQ: MLTX)